|Articles|June 16, 2019
What’s new from Bausch + Lomb for U.S. anterior segment surgeons
Author(s)Julianne Mobilian
Bausch + Lomb provides a company update at the 2019 ASCRS meeting.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA update: Outlook Therapeutics receives CRL for resubmitted ONS-5010 BLA
2
FDA approvals in 2025: What changed and why it matters for ophthalmologists
3
What changed in glaucoma care in 2025: Surgeon perspective
4
PRIMAvera study: Central vision improvement with subretinal implant
5








































